Boston, MA -- (SBWIRE) -- 12/03/2013 -- At winstonsmallcap.com we focus on undervalued companies trading under $5. Right now the markets are surging and we are seeing an opportunity in micro-cap companies like we have never seen before. Let have a Look on: Arrowhead Research Corp (NASDAQ:ARWR), Tribune Company (OTCMKTS:TRBAA), Array Biopharma Inc (NASDAQ:ARRY), Annaly Capital Management, Inc. (NYSE:NLY).
Arrowhead Research Corp (NASDAQ:ARWR), opened its shares at the price of $8.34for the day. Its closing price was $9.01 after gaining9.48% for the day. The company traded with the total volume of 1.51 million shares, while its average trading volume remained 406,678 shares. The beta of ARWR stands at2.69.
Will ARWR Continue To Move Higher? Find Out Here
Arrowhead Research Corporation operates as a clinical stage therapeutics company. It has development programs in oncology, obesity, and chronic hepatitis B virus (HBV) infection.
Tribune Company (OTCMKTS:TRBAA), percentage change surged0.01 % to close at $74.51 with the total traded volume of 527,501 shares, and average volume of 338,034. The 52 week range of the stock remained $48.38- $75.00, while its day lowest price was $74.30 and it hit its day highest price at $74.85.
Will TRBAA Continue To Move Higher? Find Out Here
Tribune Company, through its subsidiaries, operates as a media and entertainment company primarily in the United States.
Array Biopharma Inc (NASDAQ:ARRY), started its trading session with the price of $5.64 and closed at $5.80 by scoring 1.40%. ARRY’s stocks traded with total volume of 3.87 million shares, while the average trading volume remained 1.68 million shares. The beta of ARRY stands at 1.67. Day range of the stock was $5.57 -$5.83.
-Will ARRY Get Buyers Even After The Recent Rally? Find Out Here
Array BioPharma Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of small molecule drugs to treat patients afflicted with cancer and inflammatory diseases primarily in North America, Europe, and the Asia Pacific.
Annaly Capital Management, Inc. (NYSE:NLY) ended its day with the loss of -1.48% and closed at the price of $10.01 after opening at $10.18. Stock traded during its last trading session with the total volume of 14.63 million shares, as compared to its average volume of 16.23 million shares.
Will NLY Get Buyers Even After The Recent Rally? Find Out Here
Annaly Capital Management, Inc. owns, manages, and finances a portfolio of real estate related investments in United States.
Here at Winston we focus on undervalued companies trading under $5. Right now the markets are surging and we are seeing an opportunity in micro-cap companies like we have never seen before. We focus on companies that we feel are trading at a discount to the market for various reasons. Enter your email and track our performance! We are sure you won’t be disappointed.
http://winstonsmallcap.com/ and its owners, and their affiliates, directors and officers, and immediate family members, are hereafter collectively referred to as “WSC” or “we” or “us” or “our”). WSC publishes information (the “Information”) about publicly traded companies (the “Profiled Company” or the “Profiled Companies”) which has been obtained from various sources including publicly available sources on the internet. WSC does not undertake any due diligence or investigation of the Information it obtains or publishes.
Read Full Disclaimer at: http://winstonsmallcap.com/disclaimer
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)